Please login to the form below
13
Revenue 2017Bristol-Myers Squibb
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.
Bristol Myers Squibb announces data on Zeposia from DAYBREAK study in MS
Bristol Myers Squibb has announced interim results from the phase 3 extension trial DAYBREAK, demonstrating the long-term efficacy and safety profile of Zeposia (ozanimod) in patients with relapsing forms of ... Immunology and Fibrosis Development,
Helping Head and Neck cancer survivors overcome barriers to employment
That’s why Bristol Myers Squibb partnered with key patient groups and charities related to Head and Neck cancer and going back-to-work. ... Helping Head and Neck cancer survivors overcome barriers to employment - by Aurora Healthcare Communications for
The London Testing Alliance
by Aurora Healthcare Communications for Bristol Myers Squibb. ... Helping Head and Neck cancer survivors overcome barriers to employment - by Aurora Healthcare Communications for Bristol Myers Squibb.
I Am Number 17 - Raising Awareness of Rare Disease Across the UK
by Aurora Healthcare Communications for Bristol Myers Squibb. ... Helping Head and Neck cancer survivors overcome barriers to employment - by Aurora Healthcare Communications for Bristol Myers Squibb.
New Normal Same Cancer – Reversing the COVID-19 Effect on Cancer Care
by Aurora Healthcare Communications for Bristol Myers Squibb. ... Helping Head and Neck cancer survivors overcome barriers to employment - by Aurora Healthcare Communications for Bristol Myers Squibb.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
Senior Account Manager
-
Competitive salary offered
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
- US demand for COVID-19 antibody treatments rising fast
- Assessing the value of interim analyses in clinical trials
- AstraZeneca chooses Ireland for $360m manufacturing site
- Breaking the silence: It’s time to talk about the menopause
- FDA accepts Regeneron’s REGEN-COV for priority review for treatment of COVID-19
- New data shows Roche's Enspryng significantly reduces neuromyelitis optica spectrum disorder relapses
- Beyond yoga and smoothies – providing real support for employee well-being
- Driving Healthcare Decisions with Natural Language Processing
- FDA approves Eli Lilly’s Verzenio in high risk early breast cancer
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- Novo Nordisk settles US insulin pricing dispute for $100m
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Onyx Health appoints Dean Forbes
- Sandoz completes acquisition of GSK’s cephalosporin business
- Public is more comfortable with health data sharing if they know it is to support breakthrough treatments and vaccines
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...
Latest intelligence
- Breaking the silence: It’s time to talk about the menopause
- Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
- Committing time to making meaningful connections - top 5 tips
- Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
- News:
- Senior Analytics Specialist joins Research Partnership...
